Pfizer, Takeda and Alphabet-backed degenerative disease drug developer Cortexyme priced its initial public offering in the middle of its range to raise $75m.

Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.

TigerMed-backed brain monitor developer Neural Analytics boosted its total funding to $66m in a series C round led by existing investor Alpha Edison.

Therachon, which had raised $100m from investors including Pfizer Ventures and Novo, has agreed to be acquired by Pfizer in a deal that could potentially reach $810m.

GV led a $58.5m round for the heart disease drug developer, which came in the wake of a partnership with another Alphabet subsidiary, Verily.

Bennett, Coleman & Co has exited online pharmacy Myra and will receive shares in its new owner, Medlife, as part of the acquisition deal.

Texas Medical Center was among the investors in a series A round for the nursing recruitment platform, a graduate of the corporate's accelerator.

Shionogi has participated in an $11m round for flu detection device developer Aillis in connection with the formation of a partnership agreement.

Existing backer Samsung Ventures contributed to a round that boosted the health maintenance platform developer's overall funding to more than $86m.

Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.